Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Leqvio
Pharma
Novartis pads case for broader use of heart med Leqvio
With a positive phase 3, Novartis aims to apply cholesterol-lowering Leqvio across the "full spectrum" of atherosclerotic cardiovascular disease.
Zoey Becker
Aug 28, 2024 11:29am
Novartis scraps key UK Leqvio study
Mar 22, 2023 11:55am
Novartis delays Pluvicto filing after FDA requests more data
Feb 1, 2023 11:19am
What does Novartis' 'US first' mindset mean? US chief explains
Jan 17, 2023 11:54am
UK government press for Rx meds ‘often overtly promotional': BMJ
Sep 28, 2022 9:20am
Novartis dons 'US-first' mindset amid groupwide overhaul
Sep 22, 2022 11:00am
